The lifetime risk of each cancer in people with Lynch syndrome is gene-specific and may be modified by environmental factors.
Furthermore, the benefits of surveillance strategies need to be balanced against the risk of over-diagnosis and be supported by evidence of improved outcomes from cancer diagnosis in surveillance.
Therefore, people with Lynch syndrome may benefit from a personalised management approach.
Lynch Syndrome Ireland 